Literature DB >> 9444333

Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease.

A Morita1, Y Imada, H Igarashi, T Yutsudo.   

Abstract

Kawasaki disease (KD) is an acute multisystem vasculitis of unknown etiology and is associated with marked activation of T cells and monocyte macrophages, leading to the assumption that superantigens are involved in its pathogenesis. To determine if an association exists between streptococcal superantigens and KD, we examined serum antibody responses to superantigens in sera from 50 paired acute and convalescent KD patients using purified recombinant streptococcal superantigens, such as SPEA, SPEC, SSA and MF. We found a very low frequency of detection of anti-superantigen antibodies by ELISA and no marked IgG seroconversion to each superantigen, indicating the absence of a serological relationship between toxin-producing streptococcal infection and the onset of KD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444333     DOI: 10.1111/j.1348-0421.1997.tb01947.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.

Authors:  K Matsubara; T Fukaya; K Miwa; N Shibayama; H Nigami; H Harigaya; H Nozaki; T Hirata; K Baba; T Suzuki; A Ishiguro
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 2.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.

Authors:  T Yoshioka; T Matsutani; S Iwagami; T Toyosaki-Maeda; T Yutsudo; Y Tsuruta; H Suzuki; S Uemura; T Takeuchi; M Koike; R Suzuki
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

4.  T cell Vbeta repertoires in childhood vasculitides.

Authors:  P A Brogan; V Shah; A Bagga; N Klein; M J Dillon
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

5.  Mycoplasma pneumoniae infection in patients with Kawasaki disease.

Authors:  Mi Na Lee; Jie Hae Cha; Hye Mi Ahn; Jeong Hyun Yoo; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2011-03-31

6.  Kawasaki disease associated with Mycoplasma pneumoniae.

Authors:  Yunjia Tang; Wenhua Yan; Ling Sun; Jie Huang; Weiguo Qian; Miao Hou; Haitao Lv
Journal:  Ital J Pediatr       Date:  2016-09-08       Impact factor: 2.638

Review 7.  Pathogenetic determinants in Kawasaki disease: the haematological point of view.

Authors:  Domenico Del Principe; Donatella Pietraforte; Lucrezia Gambardella; Alessandra Marchesi; Isabella Tarissi de Jacobis; Alberto Villani; Walter Malorni; Elisabetta Straface
Journal:  J Cell Mol Med       Date:  2017-01-07       Impact factor: 5.310

Review 8.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 9.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

Review 10.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.